|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Li Z, Zheng W, Li X, Wang Z, Cui Y
and Jiang X: PANDAR: A pivotal cancer-related long non-coding RNA
in human cancers. Mol Biosyst. 13:2195–2201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu Q, Tai S and Wang J: Oncogenicity of
lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
Pathol Res Pract. 215:843–848. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adams BD, Parsons C, Walker L, Zhang WC
and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest.
127:761–771. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu S, Li W, Liu J, Chen CH, Liao Q, Xu P,
Xu H, Xiao T, Cao Z, Peng J, et al: Genome-scale deletion screening
of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9
library. Nat Biotechnol. 34:1279–1286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xue JY, Huang C, Wang W, Li HB, Sun M and
Xie M: HOXA11-AS: A novel regulator in human cancer proliferation
and metastasis. Onco Targets Ther. 11:4387–4393. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao W, Ma X, Liu L, Chen Q, Liu Z, Zhang
Z, Ma S, Wang Z, Li H, Wang Z and Wu J: SNHG20: A vital lncRNA in
multiple human cancers. J Cell Physiol. Jan 15–2019.(Epub ahead of
print). doi: 10.1002/jcp.28143.
|
|
9
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Atianand MK, Caffrey DR and Fitzgerald KA:
Immunobiology of long noncoding RNAs. Annu Rev Immunol. 35:177–198.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khorkova O, Hsiao J and Wahlestedt C:
Basic biology and therapeutic implications of lncRNA. Adv Drug
Deliv Rev. 87:15–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Borsani G, Tonlorenzi R, Simmler MC,
Dandolo L, Arnaud D, Capra V, Grompe M, Pizzuti A, Muzny D,
Lawrence C, et al: Characterization of a murine gene expressed from
the inactive X chromosome. Nature. 351:325–329. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gendrel AV and Heard E: Noncoding RNAs and
epigenetic mechanisms during X-chromosome inactivation. Annu Rev
Cell Dev Biol. 30:561–580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G and
Zhu YS: MALAT1: A potential biomarker in cancer. Cancer Manag Res.
10:6757–6768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seiler J, Breinig M, Caudron-Herger M,
Polycarpou-Schwarz M, Boutros M and Diederichs S: The lncRNA VELUCT
strongly regulates viability of lung cancer cells despite its
extremely low abundance. Nucleic Acids Res. 45:5458–5469. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma M, Xu H, Liu G, Wu J, Li C, Wang X,
Zhang S, Xu H, Ju S, Cheng W, et al: Metabolism-induced tumor
activator 1 (MITA1), an Energy Stress-inducible long noncoding RNA,
promotes hepatocellular carcinoma metastasis. Hepatology.
70:215–230. 2019.PubMed/NCBI
|
|
18
|
Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen
JJ, Chen WJ, Sun WY, Liu XM and Chen JB: lncRNA SNHG16 functions as
an oncogene by sponging MiR-4518 and Up-regulating PRMT5 expression
in Glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang FW, Cao CH, Han K, Zhao YX, Cai MY,
Xiang ZC, Zhang JX, Chen JW, Zhong LP, Huang Y, et al:
APC-activated long noncoding RNA inhibits colorectal carcinoma
pathogenesis through reduction of exosome production. J Clin
Invest. 129:727–743. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu C, Cheng D, Qiu X, Zhuang M and Liu Z:
Long noncoding RNA SNHG16 promotes cell proliferation by sponging
MicroRNA-205 and upregulating ZEB1 expression in osteosarcoma. Cell
Physiol Biochem. 51:429–440. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan H, Li H, Li P, Li X, Lin J, Zhu L,
Silva MA, Wang X, Wang P and Zhang Z: Long noncoding RNA MLK7-AS1
promotes ovarian cancer cells progression by modulating
miR-375/YAP1 axis. J Exp Clin Cancer Res. 37:2372018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhuo W, Liu Y, Li S, Guo D, Sun Q, Jin J,
Rao X, Li M, Sun M, Jiang M, et al: Long noncoding RNA GMAN,
up-regulated in gastric cancer tissues, is associated with
metastasis in patients and promotes translation of Ephrin A1 by
competitively binding GMAN-AS. Gastroenterology. 156:676–691.e11.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang E, Han L, Yin D, He X, Hong L, Si X,
Qiu M, Xu T, De W, Xu L, et al: H3K27 acetylation activated-long
non-coding RNA CCAT1 affects cell proliferation and migration by
regulating SPRY4 and HOXB13 expression in esophageal squamous cell
carcinoma. Nucleic Acids Res. 45:3086–3101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng WX, Koirala P and Mo YY:
lncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang
Y, Jia L, Li S; Cancer Genome Atlas Research Network, ; Xie W and
Yang D: lncRNA epigenetic landscape analysis identifies EPIC1 as an
oncogenic lncRNA that interacts with MYC and promotes Cell-cycle
progression in cancer. Cancer Cel. 33:706–720.e9. 2018. View Article : Google Scholar
|
|
27
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen YG, Satpathy AT and Chang HY: Gene
regulation in the immune system by long noncoding RNAs. Nat
Immunol. 18:962–972. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chu C, Zhang QC, da Rocha ST, Flynn RA,
Bharadwaj M, Calabrese JM, Magnuson T, Heard E and Chang HY:
Systematic discovery of Xist RNA binding proteins. Cell.
161:404–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Samata M and Akhtar A: Dosage compensation
of the X chromosome: A complex epigenetic assignment involving
chromatin regulators and long noncoding RNAs. Annu Rev Biochem.
87:323–350. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vallot C, Patrat C, Collier AJ, Huret C,
Casanova M, Liyakat AT, Tosolini M, Frydman N, Heard E, Rugg-Gunn
PJ and Rougeulle C: XACT noncoding RNA competes with XIST in the
control of X Chromosome activity during human early development.
Cell Stem Cell. 20:102–111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Furlan G, Gutierrez Hernandez N, Huret C,
Galupa R, van Bemmel JG, Romito A, Heard E, Morey C and Rougeulle
C: The Ftx noncoding locus controls X chromosome inactivation
independently of its RNA products. Mol Cell. 70:462–472.e8. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarma K, Cifuentes-Rojas C, Ergun A, Del
Rosario A, Jeon Y, White F, Sadreyev R and Lee JT: ATRX directs
binding of PRC2 to Xist RNA and Polycomb targets. Cell.
159:869–883. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Engreitz JM, Haines JE, Perez EM, Munson
G, Chen J, Kane M, McDonel PE, Guttman M and Lander ES: Local
regulation of gene expression by lncRNA promoters, transcription
and splicing. Nature. 539:452–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun TT, He J, Liang Q, Ren LL, Yan TT, Yu
TC, Tang JY, Bao YJ, Hu Y, Lin Y, et al: lncRNA GClnc1 promotes
gastric carcinogenesis and may act as a modular scaffold of WDR5
and KAT2A complexes to specify the histone modification pattern.
Cancer Discov. 6:784–801. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li D, Liu X, Zhou J, Hu J, Zhang D, Liu J,
Qiao Y and Zhan Q: Long noncoding RNA HULC modulates the
phosphorylation of YB-1 through serving as a scaffold of
extracellular signal-regulated kinase and YB-1 to enhance
hepatocarcinogenesis. Hepatology. 65:1612–1627. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Long Y, Wang X, Youmans DT and Cech TR:
How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu WL, Jin L, Xu A, Wang YF, Thorne RF,
Zhang XD and Wu M: GUARDIN is a p53-responsive long non-coding RNA
that is essential for genomic stability. Nat Cell Biol. 20:492–502.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bhan A and Mandal SS: Estradiol-induced
transcriptional regulation of long non-coding RNA, HOTAIR. Methods
Mol Biol. 1366:395–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: Addendum: A
regulated PNUTS mRNA to lncRNA splice switch mediates EMT and
tumour progression. Nat Cell Biol. 19:14432017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu Q, Guo L, Jiang F, Li L, Li Z and Chen
F: Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER-breast
cancer cell lines. J Cell Mol Med. 19:2874–2887. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Song YX, Sun JX, Zhao JH, Yang YC, Shi JX,
Wu ZH, Chen XW, Gao P, Miao ZF and Wang ZN: Non-coding RNAs
participate in the regulatory network of CLDN4 via ceRNA mediated
miRNA evasion. Nat Commun. 8:2892017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shen L, Wang Q, Liu R, Chen Z, Zhang X,
Zhou P and Wang Z: lncRNA lnc-RI regulates homologous recombination
repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a
competitive endogenous RNA. Nucleic Acids Res. 46:717–729. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu W, Peng W, Jiang H, Sha H and Li J:
lncRNA HOXA11-AS promotes proliferation and invasion by targeting
miR-124 in human non-small cell lung cancer cells. Tumour Biol.
39:10104283177214402017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dhir A, Dhir S, Proudfoot NJ and Jopling
CL: Microprocessor mediates transcriptional termination of long
noncoding RNA transcripts hosting microRNAs. Nat Struct Mol Biol.
22:319–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Augoff K, McCue B, Plow EF and
Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are
regulated by promoter hypermethylation in triple-negative breast
cancer. Mol Cancer. 11:52012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yu Y, Nangia-Makker P, Farhana L and
Majumdar A: A novel mechanism of lncRNA and miRNA interaction:
CCAT2 regulates miR-145 expression by suppressing its maturation
process in colon cancer cells. Mol Cancer. 16:1552017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Villamizar O, Chambers CB, Riberdy JM,
Persons DA and Wilber A: Long noncoding RNA Saf and splicing factor
45 increase soluble Fas and resistance to apoptosis. Oncotarget.
7:13810–13826. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jadaliha M, Gholamalamdari O, Tang W,
Zhang Y, Petracovici A, Hao Q, Tariq A, Kim TG, Holton SE, Singh
DK, et al: A natural antisense lncRNA controls breast cancer
progression by promoting tumor suppressor gene mRNA stability. PLoS
Genet. 14:e10078022018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-Transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rashid F, Shah A and Shan G: Long
non-coding RNAs in the cytoplasm. Genomics Proteomics
Bioinformatics. 14:73–80. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yoon JH, Abdelmohsen K, Srikantan S, Yang
X, Martindale JL, De S, Huarte M, Zhan M, Becker KG and Gorospe M:
LincRNA-p21 suppresses target mRNA translation. Mol Cell.
47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
He RZ, Luo DX and Mo YY: Emerging roles of
lncRNAs in the post-transcriptional regulation in cancer. Genes
Dis. 6:6–15. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yu J, Han Z, Sun Z, Wang Y, Zheng M and
Song C: lncRNA SLCO4A1-AS1 facilitates growth and metastasis of
colorectal cancer through β-catenin-dependent Wnt pathway. J Exp
Clin Cancer Res. 37:2222018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jiang H, Li T, Qu Y, Wang X, Li B, Song J,
Sun X, Tang Y, Wan J, Yu Y, et al: Long non-coding RNA SNHG15
interacts with and stabilizes transcription factor Slug and
promotes colon cancer progression. Cancer Lett. 425:78–87. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cui M, Wang J, Li Q, Zhang J, Jia J and
Zhan X: Long non-coding RNA HOXA11-AS functions as a competing
endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p
in osteosarcoma. Biomed Pharmacother. 92:437–444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zheng LL, Li JH, Wu J, Sun WJ, Liu S, Wang
ZL, Zhou H, Yang JH and Qu LH: deepBase v2.0: Identification,
expression, evolution and function of small RNAs, lncRNAs and
circular RNAs from deep-sequencing data. Nucleic Acids Res.
44:D196–D202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Spencer DH, Young MA, Lamprecht TL, Helton
NM, Fulton R, O'Laughlin M, Fronick C, Magrini V, Demeter RT,
Miller CA, et al: Epigenomic analysis of the HOX gene loci reveals
mechanisms that may control canonical expression patterns in AML
and normal hematopoietic cells. Leukemia. 29:1279–1289. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Garcia-Fernández J: The genesis and
evolution of homeobox gene clusters. Nat Rev Genet. 6:881–892.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kelly ZL, Michael A, Butler-Manuel S,
Pandha HS and Morgan RG: HOX genes in ovarian cancer. J Ovarian
Res. 4:162011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cheng W, Liu J, Yoshida H, Rosen D and
Naora H: Lineage infidelity of epithelial ovarian cancers is
controlled by HOX genes that specify regional identity in the
reproductive tract. Nat Med. 11:531–537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lu S, Jiang X, Su Z, Cui Z, Fu W and Tai
S: The role of the long non-coding RNA HOXA11-AS in promoting
proliferation and metastasis of malignant tumors. Cell Biol Int.
42:1596–1601. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lu CW, Zhou DD, Xie T, Hao JL, Pant OP, Lu
CB and Liu XF: HOXA11 antisense long noncoding RNA (HOXA11-AS): A
promising lncRNA in human cancers. Cancer Med. 7:3792–3799. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Xu YJ, Du Y and Fan Y: Long noncoding RNAs
in lung cancer: What we know in 2015. Clin Transl Oncol.
18:660–665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kang CG, Lee HJ, Kim SH and Lee EO:
Zerumbone suppresses Osteopontin-induced cell invasion through
inhibiting the FAK/AKT/ROCK pathway in human Non-small cell lung
cancer A549 cells. J Nat Prod. 79:156–160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Osmani L, Askin F, Gabrielson E and Li QK:
Current WHO guidelines and the critical role of immunohistochemical
markers in the subclassification of non-small cell lung carcinoma
(NSCLC): Moving from targeted therapy to immunotherapy. Semin
Cancer Biol. 52:103–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li Y, Xuan J, Song Y, Qi W, He B, Wang P
and Qin L: Nanoporous Glass integrated in volumetric Bar-chart chip
for Point-of-Care diagnostics of non-small cell lung cancer. Acs
Nano. 10:1640–1647. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhang Y, He RQ, Dang YW, Zhang XL, Wang X,
Huang SN, Huang WT, Jiang MT, Gan XN, Xie Y, et al: Comprehensive
analysis of the long noncoding RNA HOXA11-AS gene interaction
regulatory network in NSCLC cells. Cancer Cell Int. 16:892016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang Y, Chen WJ, Gan TQ, Zhang XL, Xie
ZC, Ye ZH, Deng Y, Wang ZF, Cai KT, Li SK, et al: Clinical
significance and effect of lncRNA HOXA11-AS in NSCLC: A study based
on bioinformatics, in vitro and in vivo verification. Sci Rep.
7:5567–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhang Y, Luo J, Wang X, Wang HL, Zhang XL,
Gan TQ, Chen G and Luo DZ: A comprehensive analysis of the
predicted targets of miR-642b-3p associated with the long
non-coding RNA HOXA11-AS in NSCLC cells. Oncol Lett. 15:6147–6160.
2018.PubMed/NCBI
|
|
75
|
Chen JH, Zhou LY, Xu S, Zheng YL, Wan YF
and Hu CP: Overexpression of lncRNA HOXA11-AS promotes cell
epithelial-mesenchymal transition by repressing miR-200b in
non-small cell lung cancer. Cancer Cell Int. 17:642017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhao X, Li X, Zhou L, Ni J, Yan W, Ma R,
Wu J, Feng J and Chen P: lncRNA HOXA11-AS drives cisplatin
resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Cancer Sci. 109:3068–3079. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wu F, Yin Z, Yang L, Fan J, Xu J, Jin Y,
Yu J, Zhang D and Yang G: Smoking induced extracellular vesicles
release and their distinct properties in Non-small cell lung
cancer. J Cancer. 10:3435–3443. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Vogel A, Cervantes A, Chau I, Daniele B,
Llovet J, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, et al:
Hepatocellular carcinoma: ESMO clinical practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 29 (Suppl
4):iv238–iv255. 2018. View Article : Google Scholar
|
|
79
|
Koeberle D, Dufour JF, Demeter G, Li Q,
Ribi K, Samaras P, Saletti P, Roth AD, Horber D, Buehlmann M, et
al: Sorafenib with or without everolimus in patients with advanced
hepatocellular carcinoma (HCC): A randomized multicenter,
multinational phase II trial (SAKK 77/08 and SASL 29). Ann Oncol.
27:856–861. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Tai WM, Yong WP, Lim C, Low LS, Tham CK,
Koh TS, Ng QS, Wang WW, Wang LZ, Hartano S, et al: Ann A phase Ib
study of selumetinib (AZD6244, ARRY-142886) in combination with
sorafenib in advanced hepatocellular carcinoma (HCC). Ann Oncol.
27:2210–2215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ciuleanu T, Bazin I, Lungulescu D, Miron
L, Bondarenko I, Deptala A, Rodriguez-Torres M, Giantonio B, Fox
NL, Wissel P, et al: A randomized, double-blind, placebo-controlled
phase II study to assess the efficacy and safety of mapatumumab
with sorafenib in patients with advanced hepatocellular carcinoma.
Ann Oncol. 27:680–687. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liu B, Li J, Liu X, Zheng M, Yang Y, Lyu Q
and Jin L: Long non-coding RNA HOXA11-AS promotes the proliferation
HCC cells by epigenetically silencing DUSP5. Oncotarget.
8:109509–109521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Yu J, Hong JF, Kang J, Liao LH and Li CD:
Promotion of lncRNA HOXA11-AS on the proliferation of
hepatocellular carcinoma by regulating the expression of LATS1. Eur
Rev Med Pharmacol Sci. 21:3402–3411. 2017.PubMed/NCBI
|
|
84
|
Zhan M, He K, Xiao J, Liu F, Wang H, Xia
Z, Duan X, Huang R, Li Y, He X, et al: lncRNA HOXA11-AS promotes
hepatocellular carcinoma progression by repressing miR-214-3p. J
Cell Mol Med. May 15–2018.(Epub ahead of print). doi:
10.1111/jcmm.13633. View Article : Google Scholar
|
|
85
|
Gusyatiner O and Hegi ME: Glioma
epigenetics: From subclassification to novel treatment options.
Semin Cancer Biol. 51:50–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Cohen ZR, Ramishetti S, Peshes-Yaloz N,
Goldsmith M, Wohl A, Zibly Z and Peer D: Localized RNAi
therapeutics of chemoresistant grade IV glioma using
hyaluronan-grafted lipid-based nanoparticles. ACS Nano.
9:1581–1591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang KL, Han L, Chen LY, Shi ZD, Yang M,
Ren Y, Chen LC, Zhang JX, Pu PY and Kang CS: Blockage of a
miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in
glioblastomas. Cancer Lett. 342:139–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang X, Wang K, Han L, Zhang A, Shi Z,
Zhang K, Zhang H, Yang S, Pu P, Shen C, et al: PRDM1 is directly
targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a
Dkk1-dependent manner during glioma growth. Cancer Lett.
331:211–219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Gonzalez-Quarante LH, Fernández Carballal
C, Agarwal V, Vargas Lopez AJ, Gil de Sagredo Del Corral OL and
Sola Vendrell E: Angiocentric Glioma in an elderly patient: Case
report and review of the literature. World Neurosurg.
97:755.e5–755.e10. 2017. View Article : Google Scholar
|
|
90
|
Wang Q, Zhang J, Liu Y, Zhang W, Zhou J,
Duan R, Pu P, Kang C and Han L: A novel cell cycle-associated
lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA
transcript and is a biomarker of progression in glioma. Cancer
Lett. 373:251–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Cui Y, Yi L, Zhao J and Jiang Y: Long
Noncoding RNA HOXA11-AS functions as miRNA sponge to promote the
glioma tumorigenesis through targeting miR-140-5p. DNA Cell Biol.
36:822–828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Xu C, He T, Li Z, Liu H and Ding B:
Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth,
migration and invasion of glioma cells. Biomed Pharmacother.
95:1504–1513. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Xu CH, Xiao LM, Liu Y, Chen LK, Zheng SY,
Zeng EM and Li DH: The lncRNA HOXA11-AS promotes glioma cell growth
and metastasis by targeting miR-130a-5p/HMGB2. Eur Rev Med
Pharmacol Sci. 23:241–252. 2019.PubMed/NCBI
|
|
94
|
Yang JX, Liu B, Yang BY and Meng Q: Long
non-coding RNA homeobox (HOX) A11-AS promotes malignant progression
of glioma by targeting miR-124-3p. Neoplasma. 65:505–514. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Rychahou P, Haque F, Shu Y, Zaytseva Y,
Weiss HL, Lee EY, Mustain W, Valentino J, Guo P and Evers BM:
Delivery of RNA nanoparticles into colorectal cancer metastases
following systemic administration. ACS Nano. 9:1108–1116. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhang L, Cao F, Zhang G, Shi L, Chen S,
Zhang Z, Zhi W and Ma T: Trends in and predictions of colorectal
cancer incidence and mortality in china from 1990 to 2025. Front
Oncol. 9:982019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z,
Hyslop T, Lin J, Myers RE, Li B, Jiang B, et al: Effects of cancer
stage and treatment differences on racial disparities in survival
from colon cancer: A united states population-based study.
Gastroenterology. 150:1135–1146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Li T, Xu C, Cai B, Zhang M, Gao F and Gan
J: Expression and clinicopathological significance of the lncRNA
HOXA11-AS in colorectal cancer. Oncol Lett. 12:4155–4160. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Chen D, Sun Q, Zhang L, Zhou X, Cheng X,
Zhou D, Ye F, Lin J and Wang W: The lncRNA HOXA11-AS functions as a
competing endogenous RNA to regulate PADI2 expression by sponging
miR-125a-5p in liver metastasis of colorectal cancer. Oncotarget.
8:70642–70652. 2017.PubMed/NCBI
|
|
102
|
Anastasiadi Z, Lianos GD, Ignatiadou E,
Harissis HV and Mitsis M: Breast cancer in young women: An
overview. Updates Surg. 69:313–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhang Y, Leonard M, Shu Y, Yang Y, Shu D,
Guo P and Zhang X: Overcoming Tamoxifen resistance of human breast
cancer by targeted gene silencing using multifunctional pRNA
nanoparticles. Acs Nano. 11:335–346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lemler DJ, Lynch ML, Tesfay L, Deng Z,
Paul BT, Wang X, Hegde P, Manz DH, Torti SV and Torti FM: DCYTB is
a predictor of outcome in breast cancer that functions via
iron-independent mechanisms. Breast Cancer Res. 19:252017.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Borin TF, Arbab AS, Gelaleti GB, Ferreira
LC, Moschetta MG, Jardim-Perassi BV, Iskander AS, Varma NR, Shankar
A, Coimbra VB, et al: Melatonin decreases breast cancer metastasis
by modulating Rho-associated kinase protein-1 expression. J Pineal
Res. 60:3–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
van Roosmalen W, Le Dévédec SE, Golani O,
Smid M, Pulyakhina I, Timmermans AM, Look MP, Zi D, Pont C, de
Graauw M, et al: Tumor cell migration screen identifies SRPK1 as
breast cancer metastasis determinant. J Clin Invest. 125:1648–1664.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Su J and Hu X: Long non-coding RNA
HOXA11-AS promotes cell proliferation and metastasis in human
breast cancer. Mol Med Rep. 16:4887–4894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Li W, Jia G, Qu Y, Du Q and Liu B and Liu
B: Long Non-coding RNA (lncRNA) HOXA11-AS promotes breast cancer
invasion and metastasis by regulating Epithelial-mesenchymal
transition. Med Sci Monit. 23:3393–3403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang K, Liang Q, Li X, Tsoi H, Zhang J,
Wang H, Go MY, Chiu PW, Ng EK, Sung JJ and Yu J: MDGA2 is a novel
tumour suppressor cooperating with DMAP1 in gastric cancer and is
associated with disease outcome. Gut. 65:1619–1631. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sugano K: Screening of gastric cancer in
Asia. Best Pract Res Clin Gastroenterol. 29:895–905. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z and Wang J: lncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res.
76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu Z, Chen Z, Fan R, Jiang B, Chen X,
Chen Q, Nie F, Lu K and Sun M: Over-expressed long noncoding RNA
HOXA11-AS promotes cell cycle progression and metastasis in gastric
cancer. Mol Cancer. 16:822017. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Grignon DJ and Che M: Clear cell renal
cell carcinoma. Clin Lab Med. 25:305–316. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Escudier B, Eisen T, Stadler WM, Szczylik
C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA,
et al: Sorafenib in advanced clear-cell renal-cell carcinoma. N
Engl J Med. 356:125–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Ridge CA, Pua BB and Madoff DC:
Epidemiology and staging of renal cell carcinoma. Semin Intervent
Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Yang FQ, Zhang JQ, Jin JJ, Yang CY, Zhang
WJ, Zhang HM, Zheng JH and Weng ZM: HOXA11-AS promotes the growth
and invasion of renal cancer by sponging miR-146b-5p to upregulate
MMP16 expression. J Cell Physiol. 233:9611–9619. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Robertson AG, Shih J, Yau C, Gibb EA, Oba
J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, et al:
Integrative analysis identifies four molecular and clinical subsets
in Uveal melanoma. Cancer Cell. 32:204–220.e15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Moore AR, Ceraudo E, Sher JJ, Guan Y,
Shoushtari AN, Chang MT, Zhang JQ, Walczak EG, Kazmi MA, Taylor BS,
et al: Recurrent activating mutations of G-protein-coupled receptor
CYSLTR2 in uveal melanoma. Nat Genet. 48:675–680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Coupland SE, Lake SL, Zeschnigk M and
Damato BE: Molecular pathology of uveal melanoma. Eye (Lond).
27:230–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Lu Q, Zhao N, Zha G, Wang H, Tong Q and
Xin S: lncRNA HOXA11-AS exerts oncogenic functions by repressing
p21 and miR-124 in Uveal melanoma. DNA Cell Biol. 36:837–844. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Ignarski M, Islam R and Müller RU: Long
Non-coding RNAs in Kidney disease. Int J Mol Sci. 20:E32762019.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Dong D, Mu Z, Zhao C and Sun M: ZFAS1: A
novel tumor-related long non-coding RNA. Cancer Cell Int.
18:1252018. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA,
Coppola D, Reid BM, Lin H, Teer JK, Berchuck A, Birrer MJ, et al: A
functional variant in HOXA11-AS, a novel long non-coding RNA,
inhibits the oncogenic phenotype of epithelial ovarian cancer.
Oncotarget. 6:34745–34757. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Steuer CE, El-Deiry M, Parks JR, Higgins
KA and Saba NF: An update on larynx cancer. CA Cancer J Clin.
67:31–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Qu L, Jin M, Yang L, Sun C, Wang P, Li Y,
Tian L, Liu M and Sun Y: Expression of long non-coding RNA
HOXA11-AS is correlated with progression of laryngeal squamous cell
carcinoma. Am J Transl Res. 10:573–580. 2018.PubMed/NCBI
|
|
129
|
Kim HJ, Eoh KJ, Kim LK, Nam EJ, Yoon SO,
Kim KH, Lee JK, Kim SW and Kim YT: The long noncoding RNA HOXA11
antisense induces tumor progression and stemness maintenance in
cervical cancer. Oncotarget. 7:83001–83016. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Sun XY, Wang XF, Cui YB, Cao XG, Zhao RH,
Wei HY, Cao W and Wu W: Expression level and clinical significance
of lncRNA HOXA11-AS in esophageal squamous cell carcinoma patients.
Zhonghua Zhong Liu Za Zhi. 40:186–190. 2018.(In Chinese).
PubMed/NCBI
|
|
131
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang C, Inzana JA, Mirando AJ, Ren Y, Liu
Z, Shen J, O'Keefe RJ, Awad HA and Hilton MJ: NOTCH signaling in
skeletal progenitors is critical for fracture repair. J Clin
Invest. 126:1471–1481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Wang XN, Zhang LH, Cui XD, Wang MX, Zhang
GY and Yu PL: lncRNA HOXA11-AS is involved in fracture healing
through regulating mir-124-3p. Eur Rev Med Pharmacol Sci.
21:4771–4776. 2017.PubMed/NCBI
|
|
134
|
Mirzakhani H, Litonjua AA, McElrath TF,
O'Connor G, Lee-Parritz A, Iverson R, Macones G, Strunk RC,
Bacharier LB, Zeiger R, et al: Early pregnancy vitamin D status and
risk of preeclampsia. J Clin Invest. 126:4702–4715. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Powe CE, Levine RJ and Karumanchi SA:
Preeclampsia, a disease of the maternal endothelium: The role of
antiangiogenic factors and implications for later cardiovascular
disease. Circulation. 123:2856–2869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Xu Y, Wu D, Liu J, Huang S, Zuo Q, Xia X,
Jiang Y, Wang S, Chen Y, Wang T and Sun L: Downregulated lncRNA
HOXA11-AS affects trophoblast cell proliferation and migration by
regulating RND3 and HOXA7 expression in PE. Mol Ther Nucleic Acids.
12:195–206. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Hu L, Chang L, Zhang Y, Zhai L, Zhang S,
Qi Z, Yan H, Yan Y, Luo X, Zhang S, et al: Platelets express
activated P2Y12 receptor in patients with diabetes mellitus.
Circulation. 136:817–833. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Jin QS, Huang LJ, Zhao TT, Yao XY, Lin LY,
Teng YQ, Kim SH, Nam MS, Zhang LY and Jin YJ: HOXA11-AS regulates
diabetic arteriosclerosis-related inflammation via PI3K/AKT
pathway. Eur Rev Med Pharmacol Sci. 22:6912–6921. 2018.PubMed/NCBI
|
|
139
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS
mRNA to lncRNA splice switch mediates EMT and tumour progression.
Nat Cell Biol. 19:1105–1115. 2017. View Article : Google Scholar : PubMed/NCBI
|
